BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 27896515)

  • 1. Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study.
    Klapdor R; Hillemanns P; Wölber L; Jückstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Habermann A; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Meier W; Harter P; Wimberger P; Hanker L; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Jäger M; Mahner S
    Ann Surg Oncol; 2017 May; 24(5):1314-1321. PubMed ID: 27896515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Groin Recurrences in Node Negative Vulvar Cancer Patients After Sole Sentinel Lymph Node Dissection.
    Klapdor R; Hertel H; Soergel P; Hillemanns P
    Int J Gynecol Cancer; 2017 Jan; 27(1):166-170. PubMed ID: 27870709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
    Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
    Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of individualized treatment based on sentinel lymph node biopsy for early-stage vulvar cancer].
    Tu H; Huang H; Gu H; Wan T; Feng Y; Liu J
    Zhonghua Fu Chan Ke Za Zhi; 2015 Aug; 50(8):596-602. PubMed ID: 26675183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term oncological outcomes of patients with negative sentinel lymph node in vulvar cancer. Comparative study with conventional lymphadenectomy.
    Rodríguez-Trujillo A; Fusté P; Paredes P; Mensión E; Agustí N; Gil-Ibáñez B; Del Pino M; González-Bosquet E; Torné A
    Acta Obstet Gynecol Scand; 2018 Dec; 97(12):1427-1437. PubMed ID: 30063814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes for patients with high-risk endometrial cancer undergoing sentinel lymph node assessment versus full lymphadenectomy.
    Holtzman S; Stoffels G; Flint M; Carr C; Prasad-Hayes M; Zeligs K; Blank SV
    Gynecol Oncol; 2023 Jul; 174():273-277. PubMed ID: 37270906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. F-18 fluoro-D-glucose (FDG)-positron emission tomography (PET)/computed tomography (CT) in planning of surgery and sentinel lymph node screening in vulvar cancers.
    Dolanbay M; Ozcelik B; Abdulrezzak U; Serin IS; Kutuk MS; Uludag S
    Arch Gynecol Obstet; 2016 Jun; 293(6):1319-24. PubMed ID: 26498604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial.
    Moore RG; Robison K; Brown AK; DiSilvestro P; Steinhoff M; Noto R; Brard L; Granai CO
    Gynecol Oncol; 2008 Apr; 109(1):65-70. PubMed ID: 18255128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: A comparison of the size of metastasis detected in inguinal lymph nodes.
    Robison K; Steinhoff MM; Granai CO; Brard L; Gajewski W; Moore RG
    Gynecol Oncol; 2006 Apr; 101(1):24-7. PubMed ID: 16246399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study.
    Klapdor R; Wölber L; Hanker L; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Jückstock J; Hilpert F; de Gregorio N; Hillemanns P; Fürst ST; Mahner S
    Gynecol Oncol; 2019 Sep; 154(3):565-570. PubMed ID: 31227222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study.
    Woelber L; Griebel LF; Eulenburg C; Sehouli J; Jueckstock J; Hilpert F; de Gregorio N; Hasenburg A; Ignatov A; Hillemanns P; Fuerst S; Strauss HG; Baumann KH; Thiel FC; Mustea A; Meier W; Harter P; Wimberger P; Hanker LC; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Neuser P; Mahner S
    Eur J Cancer; 2016 Dec; 69():180-188. PubMed ID: 27837710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of prognostic value of lymphovascular space invasion in patients with endometrial cancer and negative sentinel lymph nodes.
    Matanes E; Eisenberg N; Lau S; Salvador S; Ferenczy A; Pelmus M; Gotlieb WH; Kogan L
    Gynecol Oncol; 2021 Aug; 162(2):256-261. PubMed ID: 34119364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study.
    Mahner S; Jueckstock J; Hilpert F; Neuser P; Harter P; de Gregorio N; Hasenburg A; Sehouli J; Habermann A; Hillemanns P; Fuerst S; Strauss HG; Baumann K; Thiel F; Mustea A; Meier W; du Bois A; Griebel LF; Woelber L;
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25618900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary sentinel node biopsy after previous excision of the primary tumor in squamous cell carcinoma of the vulva.
    Woelber L; Grimm D; Vettorazzi E; Wisotzki C; Trillsch F; Jaenicke F; Schwarz J; Choschzick M; Mahner S
    Ann Surg Oncol; 2013 May; 20(5):1701-6. PubMed ID: 23132121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
    Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
    Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial versus deep inguinal nodal dissection for vulvar cancer staging.
    Mattson J; Emerson J; Underwood A; Sun G; Mott SL; Kulkarni A; Robison K; Hill EK
    Gynecol Oncol; 2022 Sep; 166(3):465-470. PubMed ID: 35781163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Groin surgery and risk of recurrence in lymph node positive patients with vulvar squamous cell carcinoma.
    Nooij LS; Ongkiehong PJ; van Zwet EW; Bosse T; Creutzberg CL; Gaarenstroom KN; van Poelgeest MI
    Gynecol Oncol; 2015 Dec; 139(3):458-64. PubMed ID: 26432039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of sentinel lymph node procedures in women with vulvar cancer over time in a population based study.
    Zigras T; Kupets R; Barbera L; Covens A; Liu Y; Gien LT
    Gynecol Oncol; 2019 Jun; 153(3):574-579. PubMed ID: 30876675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies?
    Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS
    World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymph node count at inguinofemoral lymphadenectomy and groin recurrences in vulvar cancer.
    van Beekhuizen HJ; Auzin M; van den Einden LC; de Hullu JA; van der Velden J; Wildhagen MF; van Doorn HC
    Int J Gynecol Cancer; 2014 May; 24(4):773-8. PubMed ID: 24662136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.